Indication
Hepatitis B prevention
Hepatitis B prevention refers to prophylactic strategies intended to avert primary infection with the hepatitis B virus (HBV), a partially double-stranded DNA virus belonging to the Hepadnaviridae family. Read more about Hepatitis B prevention
16 drugs 11 manufacturers
Drugs that treat it
Common Hepatitis B prevention therapies.
HYPERHEP B S-D (hepatitis B immune globulin)
HYPERHEP B S-D (hepatitis B immune globulin)
NABI-HB (hepatitis B immune globulin)
HYPERHEP B S-D (hepatitis B immune globulin)
HEPAGAM B (hepatitis B immune globulin/maltose)
HEPAGAM B (hepatitis B immune globulin/maltose)
HEPAGAM B (hepatitis B immune globulin/maltose)
HEPAGAM B (hepatitis B immune globulin/maltose)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHepatitis B prevention refers to prophylactic strategies intended to avert primary infection with the hepatitis B virus (HBV), a partially double-stranded DNA virus belonging to the Hepadnaviridae family.
The virus primarily targets the hepatic system via exposure to infectious blood, semen, or other bodily fluids, with perinatal transmission representing a major driver of lifelong carriage.
Susceptible populations range from newborns and unimmunized adults to individuals at elevated occupational, behavioral, or medical risk of viral exposure.
Without effective immunoprophylaxis—which typically elicits protective anti-hepatitis B surface antigen (anti-HBs) antibodies—acute infection can progress to chronic necroinflammatory liver disease, cirrhosis, and hepatocellular carcinoma, with the risk of chronicity reaching approximately 90% in perinatally infected infants.
- cdc.gov
Hepatitis B prevention refers to prophylactic strategies intended to avert primary infection with the hepatitis B virus (HBV), a partially double-stranded DNA virus belonging to the Hepadnaviridae family The virus primarily targets the hepatic system via exposure to infectious blood, semen, or other bodily fluids, with perinatal transmission representing a major driver of lifelong carriage Susceptible populations range from newborns and unimmunized adults to individuals at elevated occupational,...
- nih.gov
The virus primarily targets the hepatic system via exposure to infectious blood, semen, or other bodily fluids, with perinatal transmission representing a major driver of lifelong carriage
- cdc.gov
Susceptible populations range from newborns and unimmunized adults to individuals at elevated occupational, behavioral, or medical risk of viral exposure
- nih.gov
Without effective immunoprophylaxis—which typically elicits protective anti-hepatitis B surface antigen (anti-HBs) antibodies—acute infection can progress to chronic necroinflammatory liver disease, cirrhosis, and hepatocellular carcinoma, with the risk of chronicity reaching approximately 90% in perinatally infected infants
- nih.gov
Without effective immunoprophylaxis—which typically elicits protective anti-hepatitis B surface antigen (anti-HBs) antibodies—acute infection can progress to chronic necroinflammatory liver disease, cirrhosis, and hepatocellular carcinoma, with the risk of chronicity reaching approximately 90% in perinatally infected infants
Personalize your experience
Follow Hepatitis B prevention and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.